Health Grants
550 open opportunities. Open federal grants funding health, medicine, and public-health work, each with a plain-English eligibility summary, deadline, and award amount.
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.
ResearchersSchools & universitiesNarrow eligibilityNIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH parent opportunity supports research projects built around international collaborations between a U.S. (domestic prime) organization and foreign partners, and at least one international subproject is required. Only domestic U.S. organizations may apply as the prime; non-U.S. entities cannot apply directly, though funded foreign components are allowed. It is aimed at research institutions and universities pursuing health-related projects that need talent, populations, or resources found in other countries. Applicants should expect to manage a linked prime-and-foreign-subaward structure.
Schools & universitiesResearchersNarrow eligibilityNIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Program Project (P01) opportunity funds multi-component research programs in infectious disease and immunology, including HIV, immune dysfunction, allergy, autoimmunity, and vaccine/therapeutic/diagnostic development. Each application must include at least two related research projects plus an administrative core, so it is geared toward research institutions with established teams. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed. Clinical trials are not permitted under this NOFO.
Schools & universitiesResearchersNarrow eligibilityLimited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH award is open only to U.S. institutions located in IDeA-eligible states/jurisdictions (a fixed list including Alaska, Arkansas, Delaware, Hawaii, Kentucky, Mississippi and others) that grant doctoral degrees in health-related sciences or are NIH-funded biomedical research institutes. It funds the expansion and sustainability of existing Centers of Biomedical Research Excellence, building faculty, research projects, and core facilities. Eligibility is narrow: it is a limited competition by invitation, applicants may hold no more than three active COBRE awards, and foreign organizations and foreign components are not eligible.
Schools & universitiesResearchersNarrow eligibilityNIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Resource-Related Research Project (R24) opportunity funds the creation or support of shared scientific resources that benefit high-priority research in infectious disease and immunology. NIAID expects to use it infrequently, only when other funding mechanisms are not appropriate, so it is a narrow opportunity for research institutions. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed, and clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
The NIH Science Education Partnership Award (SEPA, R25) funds educational projects that increase understanding of biomedical research among pre-college (pre-K through grade 12) students and encourage interest in STEM careers. It suits universities, research institutions, and education-focused organizations that can run science education programs. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesNonprofitsNarrow eligibilityNIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Due Jul 5, 2029National Institutes of Health · Amount varies
This NIH/NIAID (U01) cooperative agreement funds the implementation of investigator-initiated, milestone-driven clinical trials that need enhanced oversight, optionally including mechanistic studies, for up to 5 (or extended 6-7) years. A clinical trial is required and only one trial may be proposed per application, so it suits research institutions ready to run a defined trial in infectious disease or immunology. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are both eligible to apply, and foreign components are allowed.
ResearchersSchools & universitiesResearch Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Due Jul 5, 2029National Institutes of Health · Amount varies
This NIH/NCI (U01) cooperative agreement funds research using cancer epidemiology cohort studies to address gaps in cancer causes and survivorship, including cohort infrastructure, continued follow-up, and data/biospecimen sharing. It is aimed at research institutions running or analyzing large epidemiologic cohorts. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are eligible to apply, though foreign components as defined by NIH are not allowed. Clinical trials are not permitted under this NOFO.
ResearchersSchools & universitiesNIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Due Jul 5, 2029National Institutes of Health · Up to $500K
This NIH/NIDCR (U01) cooperative agreement funds investigator-initiated observational or biomarker validation studies that require prospective collection or continued analysis of data and biospecimens, with a stated budget up to about $500,000. It is aimed at research institutions in NIDCR (dental, oral, and craniofacial) mission areas. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted under this NOFO.
ResearchersSchools & universitiesLarge awardNarrow eligibilityCausal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)
Due Jul 5, 2029National Institutes of Health · Up to $500K
This NIH (U01) cooperative agreement funds research into the human behaviors that affect oral and systemic health among people with chronic conditions, including projects that develop or test causal hypotheses, with a stated budget up to about $500,000. It is aimed at research institutions studying behavioral, biological, and psychosocial drivers of health outcomes. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted under this NOFO.
ResearchersSchools & universitiesLarge awardNarrow eligibilityBioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
Due Jul 5, 2029National Institutes of Health · Up to $500K
This NIH (R01) Bioengineering Research Grant funds multidisciplinary projects that apply engineering approaches to biomedical, clinical, or translational problems, with a stated budget up to about $500,000. It supports clinical trials that validate performance but excludes Phase III trials, conventional non-translational trials, and commercial production. Eligibility is relatively broad for an NIH grant: both foreign organizations and foreign components of U.S. organizations are eligible to apply, though foreign components (as defined by NIH) are not allowed.
ResearchersSchools & universitiesLarge awardAcademic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)
Due Jul 12, 2029National Institutes of Health · Amount varies
This NIH career development award (K32) supports up to three years of mentored research and career development for early-stage postdoctoral scholars, with applications submitted around the start of the postdoctoral position. It is an institutional/mentored mechanism aimed at developing future independent investigators, so it suits universities and research institutions. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityLimited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)
Due Jul 16, 2029National Institutes of Health · Amount varies
This NIH/NIAMS Small Grant (R03) is a limited competition restricted to existing recipients of certain mentored career development awards (K01, K08, K23, K25 or comparable federal/non-federal awards) in NIAMS mission areas. It provides up to $50,000 in direct costs per year for up to two years to support short, self-contained projects that help researchers transition to independence. Eligibility is narrow and by invitation, and only domestic U.S. organizations may apply; foreign organizations are not eligible. Clinical trials are not allowed.
Schools & universitiesResearchersNarrow eligibilitySmall awardRFA-CK-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-CK-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is listed only as a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or specific requirements provided. Because it appears intended for existing grantees, confirm with CDC whether new applicants can apply.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-TS-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-TS-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder for Type 6 (continuation/competing renewal) applications and does not state award amounts or detailed program requirements. Since it appears aimed at existing grantees filing renewal-type applications, verify eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CC-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-CC-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder for Type 6 (continuation/competing renewal) applications and gives no award amounts or program details. As it appears geared toward existing grantees, verify with CDC whether new organizations can apply.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CE-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This is a CDC health research opportunity (RFA-CE-18-000) open to a broad range of applicants, including states, universities, counties, small businesses, and nonprofit organizations. It is described only as a placeholder for Type 6 (continuation/competing renewal) applications, so funding amounts and specific program details are not stated. Because it appears geared toward existing grantees submitting renewal-type applications, confirm with CDC whether new applicants are eligible before applying.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-TP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-TP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not list award amounts or program details. Since it appears intended for existing grantees, check with CDC about eligibility before applying as a new organization.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-GH-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC global health research opportunity (RFA-GH-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder with minimal detail and no stated award amounts. Because such CDC RFA placeholders are typically used for renewal-type applications, verify with CDC whether new applicants are eligible and what the actual program scope is.
NonprofitsSmall businessResearchersGovernment / tribal+2 more